Kimberley Mak | Profiles RNS

Kimberley S. Mak, MD, MPH

Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Radiation Oncology

MD, Harvard Medical School
MPH, Harvard School of Public Health
AB, Harvard College

Websites

	BMCRO
	BMCPP
	BUMC

ORCID : 0000-0002-7388-5124

Kimberley S. Mak, MD, MPH, is an Assistant Professor of Radiation Oncology at the Chobanian and Avedisian School of Medicine and its affiliate Boston Medical Center. She received her MPH from Harvard School of Public Health (2014), MD from Harvard Medical School (2010) and AB summa cum laude in Biochemical Sciences from Harvard College (2005). Dr. Mak completed an internship in Internal Medicine at Brigham and Women's Hospital (2011), followed by residency in the Harvard Radiation Oncology Program (2015), training at Massachusetts General Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Children's Hospital of Boston, and Boston Medical Center. Dr. Mak has board certification in Radiation Oncology by the American Board of Radiology. She speaks English and Cantonese. Her specialties include thoracic, gastrointestinal, breast, and musculoskeletal malignancies. She leads the Cyberknife® radiosurgery program for thoracic and gastrointestinal malignancies.

Her research interests include patient-reported outcomes including quality of life; disparity outcomes research; translational research; intensity-modulated and image-guided radiotherapy; CyberKnife® stereotactic radiotherapy; and functional imaging in radiotherapy. She has training and experience in biostatistics, epidemiology, decision analysis, meta-analysis, clinical trial design, and molecular and cell biology laboratory work.

Member
Boston University
BU-BMC Cancer Center

Boston Medical Center

VA Boston Healthcare System

BMC Research

Improving PRO Interpretation at the Individual Level for Patients with Cancer using Conversational Agents and Data Visualization
03/01/2023 - 02/28/2024 (PI)
Tufts Medical Center National Cancer Inst
7R01CA271145-02

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Mak KS, Scannell Bryan M, Dignam JJ, Shipley WU, Lin Y, Peters CA, Gore EM, Rosenthal SA, Zeitzer KL, D'Souza DP, Horwitz EM, Pisansky TM, Maier JM, Chafe SM, Robin TP, Roach M, Tran PT, Souhami L, Michalski JM, Hartford AC, Feng FY, Sandler HM, Efstathiou JA. Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202. Eur Urol Focus. 2024 Feb 01. PMID: 38307806

Dudipala H, Burns L, Jani CT, Radwan A, Al Omari O, Patel M, Kilic S, Zhao J, Mak K, Suzuki K, Tapan U. Disparities in Lung Cancer Clinical Trial Discussion and Enrollment at a Safety Net Hospital. Community Health Equity Res Policy. 2023 Dec 12; 2752535X231221394.View Related Profiles.

Zhao, Jenny
Mak, Kimberley
Burns, Laura
Tapan, Umit

PMID: 38087807

Qureshi MM, Lin Y, Moeller AR, Yan SX, Dyer MA, Suzuki K, Everett P, Litle V, Truong MT, Mak KS. Change in stage after neoadjuvant chemoradiation is associated with survival in patients with esophageal cancer. J Surg Oncol. 2023 Oct; 128(5):781-789.View Related Profiles.

Mak, Kimberley
Qureshi, Muhammad
Everett, Peter
Litle, Virginia

PMID: 37288789

Qureshi MM, Kam A, Suzuki K, Litle V, Tapan U, Balasubramaniyan R, Dyer MA, Truong MT, Mak KS. Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer. Surgery. 2023 May; 173(5):1153-1161.View Related Profiles.

Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Balasubramaniyan, Ramkumar
Tapan, Umit
Litle, Virginia

PMID: 36774317

Oladeru OT, Lam CM, Qureshi MM, Hirsch AE, Mak KS, Dyer MA, Truong MT. Inequalities in Cancer Stage at Diagnosis Among Incarcerated Individuals Undergoing Radiation Therapy at a Large Safety-Net Hospital. Int J Radiat Oncol Biol Phys. 2023 May 01; 116(1):194-198.View Related Profiles.

Hirsch, Ariel
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad

PMID: 36758643

Asokan S, Pavesi F, Bains A, Qureshi MM, Shetty S, Singh S, Mak KS, Litle VR, Suzuki K. Frailty Index is Associated with Treatment Decisions for Stage I Non-Small Cell Lung Cancer at a High-Burden Safety-Net Hospital. Clin Lung Cancer. 2023 Mar; 24(2):153-164.View Related Profiles.

Bains, Ashank
Mak, Kimberley
Qureshi, Muhammad
Litle, Virginia

PMID: 36641324

Siddiqi N, Pan G, Liu A, Lin Y, Jenkins K, Zhao J, Mak K, Tapan U, Suzuki K. Timeliness of Lung Cancer Care From the Point of Suspicious Image at an Urban Safety Net Hospital. Clin Lung Cancer. 2023 Mar; 24(2):e87-e93.View Related Profiles.

Pan, Gilbert
Zhao, Jenny
Mak, Kimberley
Tapan, Umit

PMID: 36642641

Liu A, Siddiqi N, Tapan U, Mak KS, Steiling KA, Suzuki K. Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net Hospital. J Racial Ethn Health Disparities. 2023 Dec; 10(6):2836-2843.View Related Profiles.

Steiling, Katrina
Mak, Kimberley
Tapan, Umit

PMID: 36441493

Lee MH, Qureshi MM, Suzuki K, Everett P, Tapan U, Mak KS. Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survival. J Thorac Dis. 2022 Aug; 14(8):2880-2893.View Related Profiles.

Mak, Kimberley
Lee, Michelle
Qureshi, Muhammad
Everett, Peter
Tapan, Umit

PMID: 36071763; PMCID: PMC9442513; DOI: 10.21037/jtd-22-210;

Matthews BJ, Qureshi MM, Fiascone SJ, Nitschmann CC, Oladeru OT, Truong MT, Hirsch AE, Mak KS, Dyer MA. Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Gynecol Oncol. 2022 01; 164(1):27-33.View Related Profiles.

Hirsch, Ariel
Matthews, Benjamin
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Fiascone, Stephen

PMID: 34785030; PMCID: PMC8711036; DOI: 10.1016/j.ygyno.2021.10.028;

Showing 10 of 43 results. Show More

Huang D, Qureshi MM, Sarfaty S, Truong MT, Dyer MA, Mak KS, Hirsch AE. Longitudinal Outcomes of Medical Student Research Mentorship: a 15-Year Analysis of the Radiation Oncology Mentorship Initiative. J Cancer Educ. 2023 Feb; 38(1):153-160.View Related Profiles.

Hirsch, Ariel
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Sarfaty, Suzanne

PMID: 34558038; DOI: 10.1007/s13187-021-02091-2;

Lin Y, Mak KS. Racial and socioeconomic disparities in the use of stereotactic body radiotherapy for treating non-small cell lung cancer: a narrative review. J Thorac Dis. 2021 Jun; 13(6):3764-3771. PMID: 34277068; PMCID: PMC8264671; DOI: 10.21037/jtd-20-3199;

Lau KHV, Hamlyn E, Williams TJ, Qureshi MM, Mak K, Mian A, Cervantes-Arslanian A, Zhu S, Takahashi C. The Effects of Video Instruction on Neuroscience Intensive Care Unit Nursing Skills in Case Presentations and Neurological Examinations. J Neurosci Nurs. 2021 Jun 01; 53(3):129-133.View Related Profiles.

Cervantes-Arslanian, Anna
Mian, Asim
Takahashi, Courtney
Hamlyn, Emily
Lau, K.H. Vincent
Mak, Kimberley
Qureshi, Muhammad
Zhu, Shuhan

PMID: 33840806; DOI: 10.1097/JNN.0000000000000591;

Annesi CA, Poulson MR, Mak KS, Tapan U, Dechert TA, Litle VR, Suzuki K. The Impact of Residential Racial Segregation on Non-Small Cell Lung Cancer Treatment and Outcomes. Ann Thorac Surg. 2022 04; 113(4):1291-1298.View Related Profiles.

Suzuki, Kei
Mak, Kimberley
Poulson, Michael
Dechert, Tracey
Tapan, Umit
Litle, Virginia

PMID: 34033745

Shah NK, Qureshi MM, Dyer MA, Truong MT, Mak KS. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival. J Gastrointest Cancer. 2021 Mar; 52(1):229-236.View Related Profiles.

Mak, Kimberley
Dyer, Michael
Truong, Minh
Qureshi, Muhammad

PMID: 32152823

Qureshi MM, Oladeru OT, Lam CM, Dyer MA, Mak KS, Hirsch AE, Truong MT. Disparities in Laryngeal Cancer Treatment and Outcomes: An Analysis by Hospital Safety-Net Burden. Laryngoscope. 2021 06; 131(6):E1987-E1997.View Related Profiles.

Hirsch, Ariel
Mak, Kimberley
Dyer, Michael
Truong, Minh
Qureshi, Muhammad

PMID: 33555062

Tapan U, Furtado VF, Qureshi MM, Everett P, Suzuki K, Mak KS. Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC. JTO Clin Res Rep. 2021 Jan; 2(1):100109.View Related Profiles.

Suzuki, Kei
Mak, Kimberley
Qureshi, Muhammad
Everett, Peter
Tapan, Umit

PMID: 34589974; PMCID: PMC8474393; DOI: 10.1016/j.jtocrr.2020.100109;

Moeller AR, Clancy PE, Qureshi MM, Guill JR, Dyer MA, Hirsch AE, Truong MT, Mak KS. Placard in Hand: A Simple, Inexpensive Intervention to Improve On-Treatment Visit Compliance in a Safety Net Radiation Oncology Patient Population. JCO Oncol Pract. 2020 11; 16(11):e1272-e1281.View Related Profiles.

Hirsch, Ariel
Mak, Kimberley
Dyer, Michael
Truong, Minh
Qureshi, Muhammad

PMID: 32936711

Yu S, Xu H, Sinclair A, Zhang X, Langner U, Mak K. Dosimetric and planning efficiency comparison for lung SBRT: CyberKnife vs VMAT vs knowledge-based VMAT. Med Dosim. 2020 Winter; 45(4):346-351.View Related Profiles.

Mak, Kimberley
Yu, Suhong

PMID: 32532613

Asokan S, Sridhar P, Qureshi MM, Bhatt M, Truong MT, Suzuki K, Mak KS, Litle VR. Presentation, Treatment, and Outcomes of Vulnerable Populations With Esophageal Cancer Treated at a Safety-Net Hospital. Semin Thorac Cardiovasc Surg. 2020 Summer; 32(2):347-354.View Related Profiles.

Suzuki, Kei
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Litle, Virginia

PMID: 31866573

Yan SX, Qureshi MM, Dyer M, Truong MT, Mak KS. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer. Lung Cancer. 2019 05; 131:147-153.View Related Profiles.

Mak, Kimberley
Dyer, Michael
Truong, Minh
Qureshi, Muhammad
Yan, Sherry

PMID: 31027693

Sridhar P, Bhatt M, Qureshi MM, Asokan S, Truong MT, Suzuki K, Mak KS, Litle VR. Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden. Ann Thorac Surg. 2019 05; 107(5):1472-1479.View Related Profiles.

Suzuki, Kei
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Litle, Virginia

PMID: 30605641

Yan SX, Qureshi MM, Suzuki K, Dyer M, Truong MT, Litle V, Mak KS. Definitive treatment patterns and survival in stage II non-small cell lung cancer. Lung Cancer. 2018 10; 124:135-142.View Related Profiles.

Suzuki, Kei
Mak, Kimberley
Dyer, Michael
Truong, Minh
Qureshi, Muhammad
Yan, Sherry
Litle, Virginia

PMID: 30268452

Mak KS, Lee SW, Balboni TA, Marcus KJ. Clinical outcomes and toxicity following palliative radiotherapy for childhood cancers. Pediatr Blood Cancer. 2018 Jan; 65(1). PMID: 28853208

Giacalone NJ, Qureshi MM, Mak KS, Kirke D, Patel SA, Shah BA, Salama AR, Jalisi S, Truong MT. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer. Laryngoscope. 2018 04; 128(4):831-840.View Related Profiles.

Salama, Andrew
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Jalisi, Scharukh

PMID: 28833217

Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 2017 Jun 01; 3(6):827-831. PMID: 27892978; PMCID: PMC5824323; DOI: 10.1001/jamaoncol.2016.3834;

Yan SX, Qureshi MM, Truong MT, Mak KS. Patterns of Care and Survival Outcomes in Stage II Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):251. PMID: 28587045

Mak KS, Agarwal A, Qureshi MM, Truong MT. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database. Cancer Med. 2017 Jun; 6(6):1192-1200.View Related Profiles.

Mak, Kimberley
Truong, Minh
Qureshi, Muhammad

PMID: 28440040; PMCID: PMC5463088; DOI: 10.1002/cam4.1070;

Patel SA, Qureshi MM, Mak KS, Sahni D, Giacalone NJ, Ezzat W, Jalisi S, Truong MT. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection. Head Neck. 2017 Jul; 39(7):1371-1377.View Related Profiles.

Sahni, Debjani
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Jalisi, Scharukh
Ezzat, Waleed

PMID: 28370725; DOI: 10.1002/hed.24776;

Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, Matthews J, Drumm MR, Nielsen ME, Feldman AS, Lee RJ, Zietman AL, Chen RC, Shipley WU, Milowsky MI, Efstathiou JA. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys. 2016 Dec 01; 96(5):1028-1036. PMID: 27727064; DOI: 10.1016/j.ijrobp.2016.08.023;

Mak KS, van Bommel AC, Stowell C, Abrahm JL, Baker M, Baldotto CS, Baldwin DR, Borthwick D, Carbone DP, Chen AB, Fox J, Haswell T, Koczywas M, Kozower BD, Mehran RJ, Schramel FM, Senan S, Stirling RG, van Meerbeeck JP, Wouters MW, Peake MD. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J. 2016 Sep; 48(3):852-60. PMID: 27390281; PMCID: PMC5007221; DOI: 10.1183/13993003.02049-2015;

Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. Int J Radiat Oncol Biol Phys. 2016 Oct 01; 96(2):406-13. PMID: 27598807; PMCID: PMC5575932; DOI: 10.1016/j.ijrobp.2016.06.006;

Kekre N, Mak KS, Stopsack KH, Binder M, Ishii K, Brånvall E, Cutler CS. Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis. Am J Hematol. 2016 Jun; 91(6):551-5. PMID: 26927727; DOI: 10.1002/ajh.24342;

Delhorme JB, Antoni D, Mak KS, Severac F, Freel KC, Schumacher C, Rohr S, Brigand C, Noel G. Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers. Crit Rev Oncol Hematol. 2016 May; 101:131-8. PMID: 26995081; DOI: 10.1016/j.critrevonc.2016.03.001;

Mak KS, Phillips JG, Barysauskas CM, Lee LK, Mannarino EG, Van Benthuysen L, Raut CP, Mullen JT, Fairweather M, DeLaney TF, Baldini EH. Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):360-6. PMID: 27009922; DOI: 10.1016/j.prro.2015.12.005;

Mak KS, Harris JR. Radiotherapy Issues After Neoadjuvant Chemotherapy. J Natl Cancer Inst Monogr. 2015 May; 2015(51):87-9. PMID: 26063895; DOI: 10.1093/jncimonographs/lgv003;

Mak KS, Chen YH, Catalano PJ, Punglia RS, Wong JS, Truong L, Bellon JR. Dosimetric Inhomogeneity Predicts for Long-Term Breast Pain After Breast-Conserving Therapy. Int J Radiat Oncol Biol Phys. 2015 Dec 1; 93(5):1087-95. PMID: 25084611; DOI: 10.1016/j.ijrobp.2014.05.021;

Mak KS, Gainor JF, Niemierko A, Oh KS, Willers H, Choi NC, Loeffler JS, Sequist LV, Shaw AT, Shih HA. Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. Neuro Oncol. 2015 Feb; 17(2):296-302. PMID: 25053852; PMCID: PMC4288518; DOI: 10.1093/neuonc/nou146;

Damato AL, Townamchai K, Albert M, Bair RJ, Cormack RA, Jang J, Kovacs A, Lee LJ, Mak KS, Mirabeau-Beale KL, Mouw KW, Phillips JG, Pretz JL, Russo AL, Lewis JH, Viswanathan AN. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2014 Jul 1; 89(3):674-81. PMID: 24803035; PMCID: PMC4180236; DOI: 10.1016/j.ijrobp.2014.03.005;

Mak KS, Lee LK, Mak RH, Wang S, Pile-Spellman J, Abrahm JL, Prigerson HG, Balboni TA. Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998-2006. Int J Radiat Oncol Biol Phys. 2011 Jul 1; 80(3):824-31. PMID: 20630663; DOI: 10.1016/j.ijrobp.2010.03.022;

Kollmeier MA, Katz MS, Mak K, Yamada Y, Feder DJ, Zhang Z, Jia X, Shi W, Zelefsky MJ. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1; 79(3):713-8. PMID: 20452139; DOI: 10.1016/j.ijrobp.2009.12.006;

Yang DP, Zhang DP, Mak KS, Bonder DE, Pomeroy SL, Kim HA. Schwann cell proliferation during Wallerian degeneration is not necessary for regeneration and remyelination of the peripheral nerves: axon-dependent removal of newly generated Schwann cells by apoptosis. Mol Cell Neurosci. 2008 May; 38(1):80-8. PMID: 18374600; PMCID: PMC2440648; DOI: 10.1016/j.mcn.2008.01.017;

Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA. Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci. 2005 Mar 30; 25(13):3478-87. PMID: 15800203; PMCID: PMC6724908; DOI: 10.1523/JNEUROSCI.3766-04.2005;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 43 publications over 14 distinct years, with a maximum of 7 publications in 2021

Bar chart showing 43 publications over 14 distinct years, with a maximum of 7 publications in 2021

Year	Publications
2005	1
2008	1
2010	2
2014	3
2015	2
2016	5
2017	6
2018	2
2019	2
2020	3
2021	7
2022	4
2023	4
2024	1

Media Mentions

Higher Radiation Doses Tied To Increased Longevity In Node-Negative Lung Cancer

Reuters Health via M.D./alert 4/30/2019

2008-2009 Howard Hughes Medical Institute: Medical Student Research Training Fellowship

2005 Harvard College: Phi Beta Kappa

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Anal cancer
Bile duct cancer
Colorectal cancer
Cyberknife radiosurgery
Disparity outcomes research
Esophageal cancer
Gastric cancer
Gastrointestinal malignancies
Image-guided radiotherapy
Intensity-modulated radiotherapy
Liver cancer
Lung cancer
Outcomes research
Pancreatic cancer
Patient-reported outcomes
Radiation oncology
Stereotactic body radiotherapy
Stereotactic radiosurgery
Thoracic malignancies
Translational research

Mentorship for students interested in oncology, radiation oncology, lung cancer, gastrointestinal cancer, gynecologic cancers, patient-reported outcomes including quality of life, disparities outcomes research, and outcomes research.

Available to Mentor as: (Review Mentor Role Definitions):